Hu YL - Search Results

1

Peptide modified mesenchymal stem cells as targeting delivery system transfected with miR-133b for the treatment of cerebral ischemia.

Huang B, Jiang XC, Zhang TY, Hu YL, Tabata Y, Chen Z, Pluchino S, Gao JQ. Huang B, et al. Among authors: hu yl. Int J Pharm. 2017 Oct 5;531(1):90-100. doi: 10.1016/j.ijpharm.2017.08.073. Epub 2017 Aug 18. Int J Pharm. 2017. PMID: 28827201

2

Gene-carried chitosan-linked-PEI induced high gene transfection efficiency with low toxicity and significant tumor-suppressive activity.

Gao JQ, Zhao QQ, Lv TF, Shuai WP, Zhou J, Tang GP, Liang WQ, Tabata Y, Hu YL. Gao JQ, et al. Among authors: hu yl. Int J Pharm. 2010 Mar 15;387(1-2):286-94. doi: 10.1016/j.ijpharm.2009.12.033. Epub 2009 Dec 24. Int J Pharm. 2010. PMID: 20035848

3

Potential neurotoxicity of nanoparticles.

Hu YL, Gao JQ. Hu YL, et al. Int J Pharm. 2010 Jul 15;394(1-2):115-21. doi: 10.1016/j.ijpharm.2010.04.026. Epub 2010 Apr 28. Int J Pharm. 2010. PMID: 20433914 Review.

4

Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy.

Hu YL, Fu YH, Tabata Y, Gao JQ. Hu YL, et al. J Control Release. 2010 Oct 15;147(2):154-62. doi: 10.1016/j.jconrel.2010.05.015. Epub 2010 May 19. J Control Release. 2010. PMID: 20493219 Review.

5

Preparation, characterisation and anti-tumour activity of Ganoderma lucidum polysaccharide nanoparticles.

Li N, Hu YL, He CX, Hu CJ, Zhou J, Tang GP, Gao JQ. Li N, et al. Among authors: hu cj, hu yl. J Pharm Pharmacol. 2010 Jan;62(1):139-44. doi: 10.1211/jpp.62.01.0016. J Pharm Pharmacol. 2010. PMID: 20723010

6

Effective gene delivery to mesenchymal stem cells based on the reverse transfection and three-dimensional cell culture system.

He CX, Li N, Hu YL, Zhu XM, Li HJ, Han M, Miao PH, Hu ZJ, Wang G, Liang WQ, Tabata Y, Gao JQ. He CX, et al. Among authors: hu yl, hu zj. Pharm Res. 2011 Jul;28(7):1577-90. doi: 10.1007/s11095-011-0390-0. Epub 2011 Feb 24. Pharm Res. 2011. PMID: 21347566

7

Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells.

Diao YY, Li HY, Fu YH, Han M, Hu YL, Jiang HL, Tsutsumi Y, Wei QC, Chen DW, Gao JQ. Diao YY, et al. Among authors: hu yl. Int J Nanomedicine. 2011;6:1955-62. doi: 10.2147/IJN.S23099. Epub 2011 Sep 12. Int J Nanomedicine. 2011. PMID: 21976972 Free PMC article.

8

Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model.

Hu YL, Qi W, Han F, Shao JZ, Gao JQ. Hu YL, et al. Int J Nanomedicine. 2011;6:3351-9. doi: 10.2147/IJN.S25853. Epub 2011 Dec 14. Int J Nanomedicine. 2011. PMID: 22267920 Free PMC article.

9

Impregnation of plasmid DNA into three-dimensional PLGA scaffold enhances DNA expression of mesenchymal stem cells in vitro.

Miao PH, He CX, Hu YL, Tabata Y, Gao JQ, Hu ZJ. Miao PH, et al. Among authors: hu yl, hu zj. Pharmazie. 2012 Mar;67(3):229-32. Pharmazie. 2012. PMID: 22530304

10

Gene-carried hepatoma targeting complex induced high gene transfection efficiency with low toxicity and significant antitumor activity.

Zhao QQ, Hu YL, Zhou Y, Li N, Han M, Tang GP, Qiu F, Tabata Y, Gao JQ. Zhao QQ, et al. Among authors: hu yl. Int J Nanomedicine. 2012;7:3191-202. doi: 10.2147/IJN.S30909. Epub 2012 Jun 27. Int J Nanomedicine. 2012. PMID: 22811604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

656 results

Search Page

Filters